Correlation Between Shanghai Rightongene and Ningbo MedicalSystem

Can any of the company-specific risk be diversified away by investing in both Shanghai Rightongene and Ningbo MedicalSystem at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shanghai Rightongene and Ningbo MedicalSystem into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Shanghai Rightongene Biotechnology and Ningbo MedicalSystem Biotechnology, you can compare the effects of market volatilities on Shanghai Rightongene and Ningbo MedicalSystem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shanghai Rightongene with a short position of Ningbo MedicalSystem. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shanghai Rightongene and Ningbo MedicalSystem.

Diversification Opportunities for Shanghai Rightongene and Ningbo MedicalSystem

0.58

Correlation Coefficient

Shanghai Rightongene  Ningbo MedicalSystem

Very weak diversification

The 3 months correlation between Shanghai and Ningbo is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Shanghai Rightongene Biotechno and Ningbo MedicalSystem Biotechno in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ningbo MedicalSystem and Shanghai Rightongene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shanghai Rightongene Biotechnology are associated (or correlated) with Ningbo MedicalSystem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ningbo MedicalSystem has no effect on the direction of Shanghai Rightongene i.e., Shanghai Rightongene and Ningbo MedicalSystem go up and down completely randomly.

Pair Corralation between Shanghai Rightongene and Ningbo MedicalSystem

Assuming the 90 days trading horizon Shanghai Rightongene Biotechnology is expected to generate 1.8 times more return on investment than Ningbo MedicalSystem. However, Shanghai Rightongene is 1.8 times more volatile than Ningbo MedicalSystem Biotechnology. It trades about -0.02 of its potential returns per unit of risk. Ningbo MedicalSystem Biotechnology is currently generating about -0.1 per unit of risk. If you would invest  1,894  in Shanghai Rightongene Biotechnology on October 6, 2024 and sell it today you would lose (129.00) from holding Shanghai Rightongene Biotechnology or give up 6.81% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Shanghai Rightongene Biotechno  vs.  Ningbo MedicalSystem Biotechno

Shanghai Rightongene

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Shanghai Rightongene Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Ningbo MedicalSystem

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ningbo MedicalSystem Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Shanghai Rightongene and Ningbo MedicalSystem

The main advantage of trading using opposite Shanghai Rightongene and Ningbo MedicalSystem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shanghai Rightongene position performs unexpectedly, Ningbo MedicalSystem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ningbo MedicalSystem will offset losses from the drop in Ningbo MedicalSystem's long position.

The idea behind Shanghai Rightongene Biotechnology and Ningbo MedicalSystem Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.